BC Week In Review | Feb 17, 2014
Company News

DanDrit Biotech USA, Oxford BioMedica, myTomorrows cancer news

Online patient platform myTomorrows will offer patients access to DanDrit's MelCancerVac and to an undisclosed therapeutic cancer vaccine from Oxford BioMedica. MelCancerVac is a dendritic cell-based vaccine that has completed Phase II testing to treat...
Items per page:
1 - 1 of 1